Infect Chemother.  2016 Dec;48(4):350-352. 10.3947/ic.2016.48.4.350.

Predictors of Treatment Success for Multidrug Resistant Tuberculosis

• Park SW

• KMID: 2441334
• DOI: http://doi.org/10.3947/ic.2016.48.4.350

Abstract

No abstract available.

MeSH Terms

Tuberculosis*

Reference

1. World Health Organization (WHO). Global tuberculosis report 2016. Accessed 1 December 2016. Available at: http://www.who.int/tb/publications/global_report/en/.

2. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, Lee JK, Kim SJ. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis. 2007; 11:571–576.

3. Park WS, Kang HY, Kim SJ, Cha JO, Son HJ, Park O. Notified tuberculosis status in Korea, 2015. Public Health Weekly Report. 2016; 9:342–345.

4. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O’Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official ATS/CDC/IDSA practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016; 63:e147–95.

5. World Health Organization (WHO). WHO treatment guidelines for drug-resistant tuberculosis, 2016 Update. Accessed 1 December 2016. Available at: http://www.who.int/tb/MDRTBguidelines2016.pdf.

6. World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis. Accessed 1 December 2016. Available at: http://apps.who.int/iris/bitstream/10665/44597/1/9789241501583_eng.pdf.

7. Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2012; 16:1335–1343.

8. Park HO, Kim SH, Moon SH, Byun JH, Kim JW, Lee CE, Kim JD, Jang IS, Yang JH. Association between body mass index and sputum culture conversion among South Korean patients with multi-drug resistant tuberculosis in a tuberculosis referral hospital. Infect Chemother. 2016; 48:317–322.

9. Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis. Int J Tuberc Lung Dis. 2016; 20:1671–1676.

10. Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb). 2012; 92:397–403.